Welcome to the Bioasis Technologies Hub On AGORACOM

Free
Message: XOMA Acquires Royalty Interest in Four Lysosomal Storage Disorder Enzymes Being Developed Under the Chiesi Group–Bioasis Strategic Alliance

An unfair exchange or what?

"Under the terms of the agreement, in exchange for a $1.2 million upfront payment, XOMA will receive a low single-digit royalty on the future net sales of each of the four Chiesi-Bioasis enzymes and an undisclosed share of the up to $138 million in potential milestones due to Bioasis under its agreement with Chiesi."

Can anyone make sense of this?

 

Koo

Share
New Message
Please login to post a reply